# A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp

> **NCT05231044** · PHASE3 · COMPLETED · sponsor: **PharmaEssentia** · enrollment: 108 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** KX01 ointment 1%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05231044
- **Lead sponsor:** PharmaEssentia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-21
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2024-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05231044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05231044, "A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05231044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*